Status:

COMPLETED

Peripheral Artery Disease in Vastmanland

Lead Sponsor:

Uppsala University

Collaborating Sponsors:

Västmanland County Council, Sweden

Conditions:

Peripheral Vascular Diseases

Heart Failure

Eligibility:

All Genders

18+ years

Brief Summary

The main purposes of this study are: * to describe the prevalence and degree of reduced left ventricular function and hypertrophy in patients with peripheral arterial disease in comparison to control...

Detailed Description

Left ventricular dysfunction is often a consequence of coronary heart disease (CHD). CHD is prevalent among patients with peripheral artery disease. However, there is limited data regarding left ventr...

Eligibility Criteria

Inclusion

  • Fulfillment of at least one of the following criteria:
  • ankle-brachial-index (ABI) \<= 0.9, or
  • stenosis of \> 30% of the internal carotid artery, or
  • symptoms typical for claudication and corresponding stenotic findings on the ultrasound examination.

Exclusion

  • age less than 18 years
  • severly impaired communication capabilities

Key Trial Info

Start Date :

May 1 2006

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 1 2011

Estimated Enrollment :

457 Patients enrolled

Trial Details

Trial ID

NCT01452165

Start Date

May 1 2006

End Date

May 1 2011

Last Update

May 8 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Center of Clinical Research, Uppsala university, Central Hospital

Västerås, Sweden, SE-72189